🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to compare rizatriptan (MK0462) 5 mg by mouth (p.o.) and sumatripta...
Status
Completed
Location
Multiple Locations
Start Date
1995-08
Trial ID
NCT00897104
Treatments Being Tested
The purpose of this study is to test the effectiveness of rizatriptan benzo...
Status
Completed
Location
Multiple Locations
Start Date
2007-10-03
Trial ID
NCT00516737
Treatments Being Tested
A study to assess the safety, tolerability, and single dose pharmacokinetic...
Status
Completed
Location
Multiple Locations
Start Date
2007-12-17
Trial ID
NCT00604812
The purpose of this study is to test the effectiveness of an approved drug ...
Status
Completed
Location
Multiple Locations
Start Date
2004-08-17
Trial ID
NCT00092963
The purpose of this study is to determine if the addition of preventive med...
Status
Completed
Location
Ohio University
Start Date
2001-07
Trial ID
NCT00910689
The purpose of this study is to test the effectiveness of a marketed drug i...
Status
Completed
Location
Multiple Locations
Start Date
2005-05-27
Trial ID
NCT00111709
The purpose of this study is to test the effectiveness of an approved drug ...
Status
Completed
Location
Multiple Locations
Start Date
2004-10-21
Trial ID
NCT00095004
This study will provide additional efficacy data for rizatriptan when used ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03-24
Trial ID
NCT00812006
Treatments Being Tested
A study to evaluate rizatriptan for the treatment of multiple attacks of ac...
Status
Completed
Location
Multiple Locations
Start Date
1995-04
Trial ID
NCT00899379
Treatments Being Tested
Rimegepant (Nurtec) is an orally administered small molecule CGRP receptor ...
Status
Recruiting
Location
Maimonides Medical Center
Start Date
2024-09-01
Trial ID
NCT06473597
Treatments Being Tested